This support will enable Every Cure to evaluate the most promising treatments identified by its ARPA-H-funded AI platform in laboratory and clinical studies, with the
News & Media
An organization scouring thousands of existing drugs to see if any can cure hard-to-treat diseases has a powerful new ally: former FDA official Janet Woodcock.
Grant Mitchell discusses Every Cure’s mission, challenges in health tech entrepreneurship, impact assessment, future innovations, and advice for aspiring entrepreneurs. Share this
Rare diseases often require innovative treatments, but not always brand-new ones. This research nonprofit deploys AI as a matchmaker between doctors and existing medications. Share
We are excited to bring you our newest patient documentary about Kaila, a rare disease patient whose life was saved thanks to a repurposed drug
The alliance will focus specifically on enhancing clinical trials and their outcomes to boost trial success rates and the efficient use of capital by drug
New Technologies Will Enable Every Cure to Bolster its Computational Drug Development, Drug Repurposing, and Clinical Trial Simulation Efforts – Uncovering More Approved Drugs to
ABC News’ Rebecca Jarvis looks at artificial intelligence’s role in the medical field and how it’s allowing doctors to expand their research and make decisions
We talk with a doctor who discovered a cure for rare diseases with the help of artificial intelligence. Share this
Every Cure was excited to announce our 3 year, 48.3M contract with ARPA-H at the White House! The ARPA-H contract is aimed to develop our
A nonprofit that seeks to repurpose approved drugs for new indications will receive more than $48 million from the U.S. Advanced Research Projects Agency for
Over the past few years, Every Cure has developed a blueprint for an AI-powered platform that can do what humans can’t — match thousands of
Every Cure, cofounded by Penn’s David Fajgenbaum, received a three-year $48 million federal contract to develop an AI tool for rare diseases. Share this
Agency backs non-profit’s agnostic approach to drug repurposing with $48.3M Share this
ABC News chief medical correspondent Dr. Jen Ashton discusses Every Cure’s AI platform that aims to match FDA-approved drugs with diseases currently lacking approved treatments.
On this Rare Disease Day, we are highlighting Madison, a patient diagnosed with a rare form of leukodystrophy (LBSL) who is fighting for her ability
The White House is hoping to use AI to match already approved drugs with untreated diseases. The federal government is giving nonprofit Every Cure nearly
New database aims to match rare-disease patients with drugs on pharmacy shelves Share this
ARPA-H contract will supercharge Every Cure’s work to identify existing medicines that can be repurposed to treat currently untreated diseases. Initial progress utilizing a pilot